AC
AKO Capital Portfolio holdings
AUM $7.92B
1-Year Return
22.47%
This Quarter Return
+10.86%
1 Year Return
+22.47%
3 Year Return
+93.1%
5 Year Return
+148.93%
10 Year Return
–
AUM
$3.93B
AUM Growth
+$622M
(+19%)
Cap. Flow
+$269M
Cap. Flow
% of AUM
6.84%
Top 10 Holdings %
Top 10 Hldgs %
63.49%
Holding
21
New
2
Increased
12
Reduced
7
Closed
–
Top Buys
| 1 |
Alcon
ALC
|
+$151M |
| 2 |
CME Group
CME
|
+$64.1M |
| 3 |
Verisk Analytics
VRSK
|
+$37.3M |
| 4 |
Zoetis
ZTS
|
+$34.4M |
| 5 |
Ambev
ABEV
|
+$27.5M |
Top Sells
| 1 |
Ferrari
RACE
|
+$31.7M |
| 2 |
Fair Isaac
FICO
|
+$27.3M |
| 3 |
RTX Corp
RTX
|
+$18.9M |
| 4 |
Moody's
MCO
|
+$14M |
| 5 |
Linde
LIN
|
+$12.5M |
Sector Composition
| 1 | Consumer Discretionary | 20.99% |
| 2 | Financials | 17.11% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Staples | 12.97% |
| 5 | Industrials | 12.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ferrari
RACE
$85.3B
| $485M | 12.33% |
2,992,168
-195,499
| -6% | -$31.7M |
|
|
2
Linde
LIN
$224B
| $394M | 10.03% |
1,963,156
-62,450
| -3% | -$12.5M |
|
3
Grifois
GRFS
$6.55B
| $265M | 6.74% |
12,562,923
+654,497
| +5% | +$13.8M |
|
4
Visa
V
$658B
| $220M | 5.58% |
1,265,414
+55,692
| +5% | +$9.67M |
|
5
Estee Lauder
EL
$31.5B
| $215M | 5.45% |
1,171,524
-28,255
| -2% | -$5.17M |
|
6
Allegion
ALLE
$15.1B
| $195M | 4.97% |
1,767,572
+12,909
| +0.7% | +$1.43M |
|
7
American Express
AXP
$228B
| $184M | 4.68% |
1,492,558
+62,372
| +4% | +$7.7M |
|
|
ANSS
8
DELISTED
Ansys
ANSS
| $184M | 4.68% |
898,998
-42,152
| -4% | -$8.63M |
|
|
9
CME Group
CME
$93.3B
| $182M | 4.62% |
935,264
+330,305
| +55% | +$64.1M |
|
10
Marriott International Class A Common Stock
MAR
$72B
| $173M | 4.41% |
1,235,952
+22,173
| +2% | +$3.11M |
|
11
Nike
NKE
$108B
| $167M | 4.25% |
1,993,021
+35,166
| +2% | +$2.95M |
|
|
12
RTX Corp
RTX
$212B
| $162M | 4.13% |
1,981,297
-230,558
| -10% | -$18.9M |
|
|
13
Fair Isaac
FICO
$37.3B
| $158M | 4.03% |
504,721
-86,815
| -15% | -$27.3M |
|
|
14
Ambev
ABEV
$36.3B
| $151M | 3.84% |
32,360,930
+5,882,307
| +22% | +$27.5M |
|
|
15
Alcon
ALC
$38.3B
| $151M | 3.83% |
+2,434,011
| New | +$151M |
|
16
Procter & Gamble
PG
$367B
| $145M | 3.68% |
1,319,947
+112,063
| +9% | +$12.3M |
|
|
17
Verisk Analytics
VRSK
$35.6B
| $140M | 3.57% |
958,842
+254,336
| +36% | +$37.3M |
|
18
Alphabet (Google) Class C
GOOG
$3.04T
| $134M | 3.41% |
2,479,300
+31,900
| +1% | +$1.72M |
|
19
Edwards Lifesciences
EW
$44.6B
| $105M | 2.68% |
1,710,762
+335,709
| +24% | +$20.7M |
|
|
20
Moody's
MCO
$91.3B
| $87.6M | 2.23% |
448,372
-71,806
| -14% | -$14M |
|
|
21
Zoetis
ZTS
$64.8B
| $34.4M | 0.87% |
+303,117
| New | +$34.4M |
|